2002
“FDA’s First Amendment Review” at the Food and Drug Law Institute
This event has already occurred.
Related Insights
Stay on Top of Hot Topics in Patent Damages Litigation
Stay on Top of Hot Topics in Patent Damages Litigation
April 18, 2024
1min
Unraveling a Tangled Net of Claims: Jury Split on a Jellyfish-Derived Supplement Product
Unraveling a Tangled Net of Claims: Jury Split on a Jellyfish-Derived Supplement Product
April 18, 2024
3min
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
April 17, 2024
2min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
April 25, 2024 Washington, DC - Venable
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
May 01 - 03, 2024 New Orleans, LA - Financial Counseling Association of America (FCAA)